Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1977 8
1978 3
1979 4
1980 4
1981 6
1982 3
1983 3
1984 6
1985 1
1986 5
1987 7
1988 12
1989 18
1990 17
1991 12
1992 27
1993 23
1994 32
1995 24
1996 37
1997 41
1998 37
1999 54
2000 48
2001 55
2002 61
2003 66
2004 89
2005 122
2006 144
2007 154
2008 159
2009 203
2010 221
2011 237
2012 236
2013 279
2014 327
2015 356
2016 360
2017 393
2018 467
2019 534
2020 613
2021 671
2022 596
2023 495
2024 192

Text availability

Article attribute

Article type

Publication date

Search Results

6,643 results

Results by year

Filters applied: . Clear all
Page 1
Breast cancer genes: beyond BRCA1 and BRCA2.
Filippini SE, Vega A. Filippini SE, et al. Front Biosci (Landmark Ed). 2013 Jun 1;18(4):1358-72. doi: 10.2741/4185. Front Biosci (Landmark Ed). 2013. PMID: 23747889 Free article. Review.
Genome wide association studies (GWAS) in BC revealed a number of common low penetrance alleles associated with a slightly increased or decreased risk of BC. Currently, only high penetrance genes are used in clinical practice on a wide scale. Due to the development of next …
Genome wide association studies (GWAS) in BC revealed a number of common low penetrance alleles associated with a slightly increased or decr …
En masse organoid phenotyping informs metabolic-associated genetic susceptibility to NASH.
Kimura M, Iguchi T, Iwasawa K, Dunn A, Thompson WL, Yoneyama Y, Chaturvedi P, Zorn AM, Wintzinger M, Quattrocelli M, Watanabe-Chailland M, Zhu G, Fujimoto M, Kumbaji M, Kodaka A, Gindin Y, Chung C, Myers RP, Subramanian GM, Hwa V, Takebe T. Kimura M, et al. Cell. 2022 Oct 27;185(22):4216-4232.e16. doi: 10.1016/j.cell.2022.09.031. Epub 2022 Oct 13. Cell. 2022. PMID: 36240780 Free PMC article.
Genotype-phenotype associations for common diseases are often compounded by pleiotropy and metabolic state. Here, we devised a pooled human organoid-panel of steatohepatitis to investigate the impact of metabolic status on genotype-phenotype association. ...Thus, "in-a-dis …
Genotype-phenotype associations for common diseases are often compounded by pleiotropy and metabolic state. Here, we devised a pooled human …
BCScreen: A gene panel to test for breast carcinogenesis in chemical safety screening.
Grashow RG, De La Rosa VY, Watford SM, Ackerman JM, Rudel RA. Grashow RG, et al. Comput Toxicol. 2018 Feb;5:16-24. doi: 10.1016/j.comtox.2017.11.003. Epub 2017 Nov 21. Comput Toxicol. 2018. PMID: 31218268 Free PMC article.
We found that many genes identified for BCScreen were not included in prognostic breast cancer or systemic toxicity panels. For example, more than half of BCScreen genes were not included in the Tox21 S1500+ general toxicity gene list. ...
We found that many genes identified for BCScreen were not included in prognostic breast cancer or systemic toxicity panels. Fo …
Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers.
Pozdeyev N, Gay LM, Sokol ES, Hartmaier R, Deaver KE, Davis S, French JD, Borre PV, LaBarbera DV, Tan AC, Schweppe RE, Fishbein L, Ross JS, Haugen BR, Bowles DW. Pozdeyev N, et al. Clin Cancer Res. 2018 Jul 1;24(13):3059-3068. doi: 10.1158/1078-0432.CCR-18-0373. Epub 2018 Apr 3. Clin Cancer Res. 2018. PMID: 29615459 Free PMC article.
Purpose: To define the genetic landscape of advanced differentiated and anaplastic thyroid cancer (ATC) and identify genetic alterations of potential diagnostic, prognostic, and therapeutic significance.Experimental Design: The genetic profiles of 583 advanced differentiat …
Purpose: To define the genetic landscape of advanced differentiated and anaplastic thyroid cancer (ATC) and identify genetic alterations of …
Characterising the spectrum of autosomal recessive hereditary hearing loss in Iran.
Sloan-Heggen CM, Babanejad M, Beheshtian M, Simpson AC, Booth KT, Ardalani F, Frees KL, Mohseni M, Mozafari R, Mehrjoo Z, Jamali L, Vaziri S, Akhtarkhavari T, Bazazzadegan N, Nikzat N, Arzhangi S, Sabbagh F, Otukesh H, Seifati SM, Khodaei H, Taghdiri M, Meyer NC, Daneshi A, Farhadi M, Kahrizi K, Smith RJ, Azaiez H, Najmabadi H. Sloan-Heggen CM, et al. J Med Genet. 2015 Dec;52(12):823-9. doi: 10.1136/jmedgenet-2015-103389. Epub 2015 Oct 7. J Med Genet. 2015. PMID: 26445815 Free PMC article.
We sought to define the spectrum of autosomal recessive HHL in Iran by investigating both common and rarely diagnosed deafness-causing genes. DESIGN: Using a custom targeted genomic enrichment (TGE) panel, we simultaneously interrogated all known genetic caus …
We sought to define the spectrum of autosomal recessive HHL in Iran by investigating both common and rarely diagnosed deafness-causing ge …
Uptake of genetic counseling and multi-gene panel testing among women in the Intermountain West with previous negative BRCA1 and BRCA2 results contacted for updated testing.
Mooney R, Espinel W, Elrick A, Kehoe K, Kohlmann W, Kaphingst KA. Mooney R, et al. J Genet Couns. 2022 Apr;31(2):470-478. doi: 10.1002/jgc4.1513. Epub 2021 Sep 27. J Genet Couns. 2022. PMID: 34570943 Free PMC article.
Eligible and interested participants were scheduled for a genetic counseling appointment to discuss updated genetic testing using a multi-gene panel. We attempted to contact 455 participants, screened 203 (45%), and 103 (23%) completed a pre-test genetic coun …
Eligible and interested participants were scheduled for a genetic counseling appointment to discuss updated genetic testing using a multi- …
Gene panel testing for hereditary breast cancer.
Winship I, Southey MC. Winship I, et al. Med J Aust. 2016 Mar 21;204(5):188-90. doi: 10.5694/mja15.01335. Med J Aust. 2016. PMID: 26985847
More recently, additional breast cancer predisposition genes, such as PALB2, have been identified. New genetic technology allows a panel of multiple genes to be tested for mutations in a single test. ...Breast cancer predisposition gene panel …
More recently, additional breast cancer predisposition genes, such as PALB2, have been identified. New genetic technology allows a …
Selection criteria for assembling a pediatric cancer predisposition syndrome gene panel.
Byrjalsen A, Diets IJ, Bakhuizen J, Hansen TVO, Schmiegelow K, Gerdes AM, Stoltze U, Kuiper RP, Merks JHM, Wadt K, Jongmans M. Byrjalsen A, et al. Fam Cancer. 2021 Oct;20(4):279-287. doi: 10.1007/s10689-021-00254-0. Epub 2021 Jun 1. Fam Cancer. 2021. PMID: 34061292 Free PMC article.
We have developed criteria to select genes relevant for childhood-onset CPS and assembled a gene panel for use in children with cancer. ...We developed evaluation criteria that determined a gene's eligibility for inclusion on a childhood-onset CPS g …
We have developed criteria to select genes relevant for childhood-onset CPS and assembled a gene panel for use in child …
The MASTiFF panel-a versatile multiple-allele SNP test for forensics.
Phillips C, Manzo L, de la Puente M, Fondevila M, Lareu MV. Phillips C, et al. Int J Legal Med. 2020 Mar;134(2):441-450. doi: 10.1007/s00414-019-02233-8. Epub 2019 Dec 21. Int J Legal Med. 2020. PMID: 31863187
Assessments of the MASTiFF panel's levels of discrimination power in the five main population groups indicate random match probabilities ranging from 10(-15) down to 10(-20)-improving the levels possible from an equivalent number of binary SNPs. ...From allele frequ …
Assessments of the MASTiFF panel's levels of discrimination power in the five main population groups indicate random match pro …
Evaluation of a Four-Gene Panel for Hereditary Cancer Risk Assessment.
Secondino A, Starnone F, Veneruso I, Di Tella MA, Conato S, De Angelis C, De Placido S, D'Argenio V. Secondino A, et al. Genes (Basel). 2022 Apr 13;13(4):682. doi: 10.3390/genes13040682. Genes (Basel). 2022. PMID: 35456488 Free PMC article.
BRCA1/2 are tumor suppressor genes involved in DNA double-strand break repair. They are the most penetrant genes for hereditary breast and ovarian cancers, but pathogenic variants in these two genes can be identified only in a fraction of hereditary cases. .. …
BRCA1/2 are tumor suppressor genes involved in DNA double-strand break repair. They are the most penetrant genes for hereditar …
6,643 results